Clinical Trial

Characterization of the Melanoma-Specific Immune Response

Study Description

Characterization of the Melanoma-Specific Immune Response

The aim of this study is to study T-cells. Blood will be collected and the samples will be used to generate T cell clones. Two separate blood draws will be required at the maximum.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.

Additional Information

Official Study Title

Characterization of the Melanoma-Specific Immune Response

Clinical Trial ID

NCT00368615

ParticipAid ID

9aADOe